Balchem Corp (BCPC) financials
Balchem revenue and earnings by year
Balchem's revenue was $1.04 billion in the fiscal year to December 31, 2025, up 8.8% from the year before. Net income was $155 million, 14.9% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 7.2% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.04 | 0.95 | 0.92 | 0.94 | 0.80 | 0.70 | 0.64 | 0.64 | 0.59 | 0.55 |
| Revenue growth | 8.8% | 3.4% | -2.1% | 17.9% | 13.6% | 9.3% | 0.0% | 8.2% | 7.5% | — |
| Gross profit | 0.37 | 0.34 | 0.30 | 0.28 | 0.24 | 0.22 | 0.21 | 0.20 | 0.19 | 0.18 |
| Gross margin | 35.7% | 35.3% | 32.7% | 29.8% | 30.4% | 31.8% | 32.8% | 31.7% | 31.8% | 32.7% |
| Operating income | 0.21 | 0.18 | 0.16 | 0.14 | 0.13 | 0.11 | 0.10 | 0.11 | 0.10 | 0.09 |
| Operating margin | 20.2% | 19.2% | 17.3% | 15.3% | 16.0% | 15.8% | 15.9% | 16.6% | 16.3% | 16.4% |
| Net income | 0.15 | 0.13 | 0.11 | 0.11 | 0.10 | 0.08 | 0.08 | 0.08 | 0.09 | 0.06 |
| Net margin | 14.9% | 13.5% | 11.8% | 11.2% | 12.0% | 12.0% | 12.4% | 12.2% | 15.1% | 10.1% |
| Diluted EPS | $4.75 | $3.93 | $3.35 | $3.25 | $2.95 | $2.60 | $2.46 | $2.43 | $2.79 | $1.75 |
| Free cash flow | 0.17 | 0.15 | 0.15 | 0.09 | 0.12 | 0.12 | 0.10 | 0.10 | 0.08 | 0.08 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open BCPC in Markets.
How Balchem makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Human Nutrition & Health | $188M | 65.2% |
| Animal Nutrition & Health | $63.0M | 21.8% |
| Specialty Products | $37.3M | 12.9% |
See also: BCPC valuation and P/E history · BCPC returns
No forecast, no recommendation. This page describes Balchem Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.